These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 38509467)

  • 1. Implementation and external validation of the Cambridge Multimorbidity Score in the UK Biobank cohort.
    Harrison H; Ip S; Renzi C; Li Y; Barclay M; Usher-Smith J; Lyratzopoulos G; Wood A; Antoniou AC
    BMC Med Res Methodol; 2024 Mar; 24(1):71. PubMed ID: 38509467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations between multimorbidity and adverse health outcomes in UK Biobank and the SAIL Databank: A comparison of longitudinal cohort studies.
    Hanlon P; Jani BD; Nicholl B; Lewsey J; McAllister DA; Mair FS
    PLoS Med; 2022 Mar; 19(3):e1003931. PubMed ID: 35255092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multimorbidity in a selected cohort compared to a representative sample: Does selection bias influence outcomes?
    Hanlon P; Bhautesh J; Mair F; McAllister D
    Ann Fam Med; 2022 Apr; 20(20 Suppl 1):. PubMed ID: 36696232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multimorbidity and the risk of malnutrition, frailty and sarcopenia in adults with cancer in the UK Biobank.
    Kiss N; Abbott G; Daly RM; Denehy L; Edbrooke L; Baguley BJ; Fraser SF; Khosravi A; Prado CM
    J Cachexia Sarcopenia Muscle; 2024 Oct; 15(5):1696-1707. PubMed ID: 39358315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility of multiorgan risk prediction with routinely collected diagnostics: a prospective cohort study in the UK Biobank.
    McCracken C; Raisi-Estabragh Z; Szabo L; Veldsman M; Raman B; Topiwala A; Roca-Fernández A; Husain M; Petersen SE; Neubauer S; Nichols TE
    BMJ Evid Based Med; 2024 Sep; 29(5):313-323. PubMed ID: 38719437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of multimorbidity and their effects on adverse outcomes in rheumatoid arthritis: a study of 5658 UK Biobank participants.
    McQueenie R; Nicholl BI; Jani BD; Canning J; Macdonald S; McCowan C; Neary J; Browne S; Mair FS; Siebert S
    BMJ Open; 2020 Nov; 10(11):e038829. PubMed ID: 33234629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multimorbidity, mortality, and HbA1c in type 2 diabetes: A cohort study with UK and Taiwanese cohorts.
    Chiang JI; Hanlon P; Li TC; Jani BD; Manski-Nankervis JA; Furler J; Lin CC; Yang SY; Nicholl BI; Thuraisingam S; Mair FS
    PLoS Med; 2020 May; 17(5):e1003094. PubMed ID: 32379755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between risk, duration and cause of hospitalisations in people with rheumatoid arthritis and multimorbidity in the UK Biobank and Scottish Early Rheumatoid Arthritis (SERA) cohorts: Longitudinal observational study.
    Morton FR; Jani BD; Mair FS; McLoone P; Canning J; Macdonald S; McQueenie R; Siebert S; Nicholl BI
    Semin Arthritis Rheum; 2023 Feb; 58():152130. PubMed ID: 36459724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multi-cancer risk stratification based on national health data: a retrospective modelling and validation study.
    Jung AW; Holm PC; Gaurav K; Hjaltelin JX; Placido D; Mortensen LH; Birney E; Brunak SR; Gerstung M
    Lancet Digit Health; 2024 Jun; 6(6):e396-e406. PubMed ID: 38789140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of the Cambridge Multimorbidity Score.
    Payne RA; Mendonca SC; Elliott MN; Saunders CL; Edwards DA; Marshall M; Roland M
    CMAJ; 2020 Feb; 192(5):E107-E114. PubMed ID: 32015079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypes and rates of cancer-relevant symptoms and tests in the year before cancer diagnosis in UK Biobank and CPRD Gold.
    Barclay M; Renzi C; Antoniou A; Denaxas S; Harrison H; Ip S; Pashayan N; Torralbo A; Usher-Smith J; Wood A; Lyratzopoulos G
    PLOS Digit Health; 2023 Dec; 2(12):e0000383. PubMed ID: 38100737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting the future risk of lung cancer: development, and internal and external validation of the CanPredict (lung) model in 19·67 million people and evaluation of model performance against seven other risk prediction models.
    Liao W; Coupland CAC; Burchardt J; Baldwin DR; ; Gleeson FV; Hippisley-Cox J
    Lancet Respir Med; 2023 Aug; 11(8):685-697. PubMed ID: 37030308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Healthy lifestyle and life expectancy in people with multimorbidity in the UK Biobank: A longitudinal cohort study.
    Chudasama YV; Khunti K; Gillies CL; Dhalwani NN; Davies MJ; Yates T; Zaccardi F
    PLoS Med; 2020 Sep; 17(9):e1003332. PubMed ID: 32960883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a modified Cambridge Multimorbidity Score for use with SNOMED CT: an observational English primary care sentinel network study.
    Tsang RS; Joy M; Whitaker H; Sheppard JP; Williams J; Sherlock J; Mayor N; Meza-Torres B; Button E; Williams AJ; Kar D; Delanerolle G; McManus R; Hobbs FR; de Lusignan S
    Br J Gen Pract; 2023 Jun; 73(731):e435-e442. PubMed ID: 37130611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Data-driven patient stratification of UK Biobank cohort suggests five endotypes of multimorbidity.
    Prasad B; Bjourson AJ; Shukla P
    Brief Bioinform; 2022 Nov; 23(6):. PubMed ID: 36209412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frailty and pre-frailty in middle-aged and older adults and its association with multimorbidity and mortality: a prospective analysis of 493 737 UK Biobank participants.
    Hanlon P; Nicholl BI; Jani BD; Lee D; McQueenie R; Mair FS
    Lancet Public Health; 2018 Jul; 3(7):e323-e332. PubMed ID: 29908859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5 year mortality predictors in 498,103 UK Biobank participants: a prospective population-based study.
    Ganna A; Ingelsson E
    Lancet; 2015 Aug; 386(9993):533-40. PubMed ID: 26049253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between multimorbidity, demographic factors and mortality: findings from the UK Biobank cohort.
    Jani BD; Hanlon P; Nicholl BI; McQueenie R; Gallacher KI; Lee D; Mair FS
    BMC Med; 2019 Apr; 17(1):74. PubMed ID: 30967141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sarcopenia, long-term conditions, and multimorbidity: findings from UK Biobank participants.
    Dodds RM; Granic A; Robinson SM; Sayer AA
    J Cachexia Sarcopenia Muscle; 2020 Feb; 11(1):62-68. PubMed ID: 31886632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multimorbidity, polypharmacy, and COVID-19 infection within the UK Biobank cohort.
    McQueenie R; Foster HME; Jani BD; Katikireddi SV; Sattar N; Pell JP; Ho FK; Niedzwiedz CL; Hastie CE; Anderson J; Mark PB; Sullivan M; O'Donnell CA; Mair FS; Nicholl BI
    PLoS One; 2020; 15(8):e0238091. PubMed ID: 32817712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.